Skip to content
  • Sunday, 26 July 2026
  • 4:37 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Gilead Sciences Pledges Over 400,000 Doses of AmBisome to Combat Visceral Leishmaniasis, Extending Vital Global Health Partnership
Pharmaceutical R&D

Gilead Sciences Pledges Over 400,000 Doses of AmBisome to Combat Visceral Leishmaniasis, Extending Vital Global Health Partnership

Teuku Ryan May 21, 2026 0

Gilead Sciences has announced a significant commitment to global health, pledging over 400,000 doses of its vital antifungal medication, AmBisome…

Read More
Biotech & Genetic Research

Groundbreaking Drug Screening Platform Developed to Combat Neurological and Psychiatric Diseases by Targeting Protein Expression Imbalances

Jia Lissa May 19, 2026 0

A pioneering drug screening platform has been successfully developed by researchers, designed to identify compounds that directly address the fundamental…

Read More
Molecular & Cell Biology

Oxford Researchers Unveil Revolutionary Food Supplement to Combat Honeybee Decline

Angie Faith Apr 27, 2026 0

A groundbreaking food supplement developed by a collaborative team of scientists, spearheaded by the University of Oxford, offers a beacon…

Read More
Biotech & Genetic Research

Groundbreaking Nasal Spray Delivers Therapeutic miRNA to Combat Neuroinflammaging and Age-Related Cognitive Decline

Jia Lissa Apr 21, 2026 0

Researchers at the Texas A&M University Naresh K. Vashisht College of Medicine (TX, USA), under the leadership of Ashok Shetty,…

Read More
Stem Cell & Regenerative Medicine

University of Hong Kong Researchers Identify Biological Exercise Sensor to Combat Osteoporosis and Bone Loss in Aging Populations

Dwi Wanna Apr 20, 2026 0

Researchers from the Department of Medicine at the School of Clinical Medicine, LKS Faculty of Medicine, University of Hong Kong…

Read More
Neuroscience & Brain Research

Canadian Researchers Identify Potential HIV Drug Repurposing to Combat Aggressive Glioblastoma Brain Tumors

Rifan Muazin Apr 16, 2026 0

In a landmark study that could redefine the treatment landscape for terminal brain cancer, a collaborative team of Canadian scientists…

Read More
Molecular & Cell Biology

Oxford-Led Research Unveils Revolutionary Food Supplement to Combat Honeybee Decline

Angie Faith Apr 11, 2026 0

A groundbreaking food supplement, engineered to precisely mimic the essential nutrients bees derive from natural pollen, has been developed by…

Read More
Pharmaceutical R&D

US Government Invests Heavily in Antibiotic Manufacturing to Combat Antimicrobial Resistance

Teuku Ryan Apr 10, 2026 0

The United States government, through the Biomedical Advanced Research and Development Authority (BARDA), has committed up to $482 million to…

Read More
Neuroscience & Brain Research

Penn Researchers Develop Breakthrough Non-Addictive Gene Therapy Targeting Brain Pain Circuits to Combat Chronic Pain and Opioid Crisis

Rifan Muazin Apr 7, 2026 0

A new preclinical study has identified a gene therapy that directly targets pain-processing areas in the brain while avoiding the…

Read More
Molecular & Cell Biology

Oxford Researchers Engineer Breakthrough Supplement to Combat Alarming Honeybee Decline

Angie Faith Apr 3, 2026 0

A groundbreaking advancement in bee nutrition has emerged from a collaborative effort led by the University of Oxford, potentially offering…

Read More

Posts pagination

1 2 3
Rethinking Western Blot Normalization: A Crucial Step Towards Enhanced Scientific ReproducibilityThe World Health Organization Targets Urgent Antibiotic Development to Combat Evolving Drug ResistanceRemepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sMastering Advanced Python Techniques: Essential Concepts for High-Performance Data Science
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ